Literature DB >> 16867261

Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis.

Ming Zhang1, Chang-Sheng Deng, Jia-Ju Zheng, Jian Xia.   

Abstract

AIM: To investigate the therapeutic effects of curcumin (Cur) on trinitrobenzene sulphonic acid (TNBS)-induced colitis and the effects of Cur on the balance of Th1/Th2 cytokines.
METHODS: Colitis was induced by TNBS and treated with Cur (30 mg/kg/d, ip), dexamethasone (Dex, 2 mg/kg/d), or Cur plus dexamethasone (Cur+Dex, 30 mg/kg/d Cur ip+2 mg/kg/d Dex,ip). mRNA in colon mucosa were detected by real-time quantitative polymerase chain reaction. Intracellular cytokines were detected by flow cytometry and concentrations of cytokines in sera were detected by enzyme-linked immunosorbent analysis.
RESULTS: Both Cur and Dex improved body weight loss, ameliorated histological images and decreased macroscopic score and myeloperoxidase activity. Cur decreased the expression of Th1 cytokines (IL-12, IFN-gamma, TNF-alpha, IL-1) and increased the expression of Th2 cytokines (IL-4 and IL-10) in colon mucosa. Cur also increased the proportion of IFN-gamma/IL-4 in splenocytes and circulation. Dex and Cur+Dex decreased the expression of Th1 cytokines but could not increase the expression of Th2 cytokines and the proportion of IFN-gamma/IL-4.
CONCLUSION: Cur exerted therapeutic effects on colitis by regulating the shift from Th1 to Th2.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16867261     DOI: 10.1111/j.1745-7254.2006.00322.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  21 in total

1.  Immunomodulatory Effects of Curcumin in Rheumatoid Arthritis: Evidence from Molecular Mechanisms to Clinical Outcomes.

Authors:  Saeed Mohammadian Haftcheshmeh; Arezou Khosrojerdi; Ali Aliabadi; Shadi Lotfi; Asadollah Mohammadi; Amir Abbas Momtazi-Borojeni
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

2.  Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease.

Authors:  C B Larmonier; M T Midura-Kiela; R Ramalingam; D Laubitz; N Janikashvili; N Larmonier; F K Ghishan; P R Kiela
Journal:  Inflamm Bowel Dis       Date:  2011-02       Impact factor: 5.325

3.  Curcumin inhibits interferon-γ signaling in colonic epithelial cells.

Authors:  Monica T Midura-Kiela; Vijayababu M Radhakrishnan; Claire B Larmonier; Daniel Laubitz; Fayez K Ghishan; Pawel R Kiela
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-10-28       Impact factor: 4.052

4.  Periplaneta americana extract ameliorates dextran sulfate sodium-induced ulcerative colitis via immunoregulatory and PI3K/AKT/NF-κB signaling pathways.

Authors:  Lianli Ni; Qian Lu; Miao Tang; Lu Tao; Hairong Zhao; Chenggui Zhang; Yun Yu; Xiumei Wu; Heng Liu; Ri Cui
Journal:  Inflammopharmacology       Date:  2022-03-18       Impact factor: 4.473

Review 5.  Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders.

Authors:  Diego Currò; Gianluca Ianiro; Silvia Pecere; Stefano Bibbò; Giovanni Cammarota
Journal:  Br J Pharmacol       Date:  2016-10-25       Impact factor: 8.739

6.  Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection.

Authors:  C B Larmonier; J K Uno; Kang-Moon Lee; T Karrasch; D Laubitz; R Thurston; M T Midura-Kiela; F K Ghishan; R B Sartor; C Jobin; P R Kiela
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-25       Impact factor: 4.052

Review 7.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

8.  Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent.

Authors:  Claire Billerey-Larmonier; Jennifer K Uno; Nicolas Larmonier; Anna J Midura; Barbara Timmermann; Fayez K Ghishan; Pawel R Kiela
Journal:  Inflamm Bowel Dis       Date:  2008-06       Impact factor: 5.325

Review 9.  On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies.

Authors:  Roja Rahimi; Shilan Mozaffari; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2008-07-10       Impact factor: 3.199

10.  Curcumin attenuates acute graft-versus-host disease severity via in vivo regulations on Th1, Th17 and regulatory T cells.

Authors:  Min-Jung Park; Su-Jin Moon; Sung-Hee Lee; Eun-Ji Yang; Jun-Ki Min; Seok-Goo Cho; Chul-Woo Yang; Sung-Hwan Park; Ho-Youn Kim; Mi-La Cho
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.